Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists
Clinical trial NCT02960880 · COMPLETED
Trial details
- NCT number
- NCT02960880
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-15
- Primary completion
- 2016-12-31
- Enrollment
- 99999
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.